Pouch Labeling (51662 1589 2 Pouch Label)
Lidocaine Hcl And Epi
Product Images NDC 51662-1589
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl And Epi (NDC 51662-1589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Case Labeling (51662 1589 3 Case Label)
XYLOCAINE® is an injectable medication containing both Lidocaine HCl and EPT, with a concentration of 160,0001%. It is available in a 58mL vial, with a strength of 500ng/50nL (16ng/nL), and there are 25 vials per case. The provided information also includes some identification numbers and codes, such as an XR number and an NDC code. However, towards the end of the text, there are some unclear characters present, suggesting errors during and rendering the text difficult to interpret.*
Serialized Label (51662 1589 3 Serialized Rfid Label)
Max Dose (Max Dose)
Precautions (Precautions)
This appears to be a chart or table listing various classes of drugs and examples of those drugs within each class. The classes include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. Specific examples of drugs within each class are also provided; for example, nitroglycerin and nitrous oxide are listed as examples of nitrates/nitrites, while lidocaine and bupivacaine are examples of local anesthetics.*
S1 (Structure 1)
S2 (Structure 2)
Vial Label (Vial Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
